Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 2 , Pages 116-120 , March 2010

Coronary artery disease in patients with peripheral artery disease

  • Nilüfer Ekşi Duran, MD

      Affiliations

    • Department of Cardiology, Kosuyolu Heart and Research Hospital, Istanbul, Turkey
    • Corresponding Author InformationCorresponding author: Nilüfer Eksi Duran, MD, Beyazkaranfil Sok No 4 D, 10 Acıbadem, İstanbul 34178, Turkey.
    • ,
  • Ibrahim Duran, MD

      Affiliations

    • Department of Cardiology, Medicana Camlıca Hospital, Istanbul, Turkey
    • ,
  • Emre Gürel, MD

      Affiliations

    • Department of Cardiology, Kosuyolu Heart and Research Hospital, Istanbul, Turkey
    • ,
  • Sebahattin Gündüz, MD

      Affiliations

    • Department of Cardiology, Kosuyolu Heart and Research Hospital, Istanbul, Turkey
    • ,
  • Gökhan Göl, MD

      Affiliations

    • Department of Cardiology, Kosuyolu Heart and Research Hospital, Istanbul, Turkey
    • ,
  • Murat Biteker, MD

      Affiliations

    • Department of Cardiology, Kosuyolu Heart and Research Hospital, Istanbul, Turkey
    • ,
  • Mehmet Özkan, MD

      Affiliations

    • Department of Cardiology, Kosuyolu Heart and Research Hospital, Istanbul, Turkey

References 

  1. Ostchage Y, Paulose-Ram R, Dillon CF, Gu Q, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J Am Geriatr Soc. 2007;55:583–589
  2. Hirsch AT, Haksal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation. 2006;113:463–654
  3. Refring TF, Sandhoff BG, Stolcpart RS, Merenich JA, Hollis HW. Atherosclerotic risk factor control in patients with peripheral artery disease. J Vasc Surg. 2005;41:816–822
  4. Ciqou HM, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann T. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381–386
  5. Sukhija R, Yalamanchili K, Aronow WS. Prevalence of left main coronary artery disease, of three- or four-vessel coronary artery disease, and of obstructive coronary artery disease in patients with and without peripheral arterial disease undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol. 2003;92:304–305
  6. Hertzer NR, Beven EG, Young JR, O'Hara PJ, Ruschhaupt WF, Graor RA, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984;199:223–233
  7. Mautner GC, Mautner SL, Roberts WC. Amount of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. Am J Cardiol. 1992;70:1147–1151
  8. Bhardwaj R, Ganju N, Sharma M, Sud S, Asotra S. Prevalence of coronary artery disease in patients with symptomatic peripheral vascular disease. Indian Heart J. 2001;53:189–191
  9. Yilmaz MB, Guray Y, Guray U, Biyikoglu SF, Tandogan I, Korkmaz S. Metabolic syndrome increases the risk of significant coronary artery involvement in patients with peripheral artery disease. Coron Artery Dis. 2006;17:529–532
  10. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors and mortality. The Whitehall Study. Circulation. 1990;82:1925–1931
  11. Kornitzer M, Dramaix M, Sobolski J, Degre S, De Backer G. Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality. Angiology. 1995;46:211–219
  12. Hertzer NR. Basing data concerning associated coronary artery disease in peripheral vascular patients. Ann Vasc Surg. 1987;1:616–620
  13. Narkiewicz K, Kjeldsen SE, Hender T. Hypertension and coronary artery disease: mechanistic insight and therapeutic challenges. Blood Pressure. 2005;14:260–261
  14. Landsberg L, Molitch M. Diabetes and hypertension: pathogenesis, prevention and treatment 1. Clinical and experimental. Hypertension. 2004;26:621–628
  15. Lenfant C, Chobanian AV, Jones DW, Roccella EJ. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Circulation. 2003;107:2993–2994
  16. Hughson WG, Mann JI, Tibbs DJ, Woods HF, Walton I. Intermittent claudication: factors determining outcome. Br Med J [Clin Res]. 1978;1:1377–1379
  17. Reunanen A, Takkunen H, Aroma A. Prevalence of intermittent claudication and its effect on mortality. Acta Med Scand. 1982;211:249–256
  18. Hooi JD, Kester ADM, Stoffers HEJH, Overdijk MM, Ree JW, Knottnerus JA. Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: a longitudinal study. Am J Epidemiol. 2001;153:666–672

PII: S0147-9563(09)00180-0

doi: 10.1016/j.hrtlng.2009.07.004

Heart & Lung: The Journal of Acute and Critical Care
Volume 39, Issue 2 , Pages 116-120 , March 2010

Article Tools

* Image Usage & Resolution